• Journal Article

Diagnosis-based risk adjustment for medicare prescription drug plan payments

Citation

Robst, J., Levy, J. M., & Ingber, M. (2007). Diagnosis-based risk adjustment for medicare prescription drug plan payments. Health Care Financing Review, 28(4), 15-30.

Abstract

The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees